Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
IMNM
#1681
Immunome, Inc.
21.8
6
+1.30%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+1.30%
Monatliche Änderung
-14.81%
6 month change
+119.26%
Jahresänderung
+151.55%
Vorheriger Schlusskurs
21.5
8
Open
21.8
6
Bid
Ask
Low
21.8
6
High
21.8
6
Volumen
116
Märkte
Aktien
Gesundheitswesen
IMNM
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
10.66 M
12.13 M
12.22 M
59.69 M
86.95 M
—
Valuation ratios
Enterprise value
63.42 M
107.94 M
19.5 M
558.55 M
780.02 M
2.57 B
Price to earnings ratio
—
-6.06
-1.06
-2.05
-2.12
-11.77
Price to sales ratio
—
14.95 K
7 906.53
13.05
28.46
114.42
Price to cash flow ratio
—
8.2
1.38
28.87
5.62
17.03
Price to book ratio
—
3.1
2.37
1.82
3.44
5.47
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.4
0.43
1.53
0.72
1.22
0.79
Return on equity %
0.43
0.51
2.22
0.89
1.62
0.96
Return on invested capital %
2 229.27
2 415.33
3 126.87
4 185.73
3 469.78
—
Gross margin %
100
100
100
100
100
400
Operating margin %
32.27 K
252.04 K
738.02 K
654.22
1 397.75
5 171.71
EBITDA margin %
—
—
—
—
—
—
Net margin %
46.84 K
247 K
738 K
637.92
1 339.08
4 927.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.12
5.82
3.09
6.63
4.08
35.6
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0.19
0.11
0.07
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.58
2.37
0.38
1.89
2.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.27
1.68
6.96
3.71
13.88
Net current asset value per share
—
4.91
1.87
7.29
3.77
14.21
Tangible book value per share
—
4.18
1.37
6.04
3.09
13.05
Working capital per share
—
4.07
1.26
6.19
2.85
12.28
Book value per share
—
4.18
1.37
6.04
3.09
13.05
Nachrichten
Immunome stock hits 52-week high at $26.74
Immunome-Aktie erreicht 52-Wochen-Hoch bei 25,32 $
Immunome stock reaches 52-week high at $25.32
Insiderkauf bei Immunome: CEO Siegall investiert 100.000 $ in Aktien/n
Immunome (IMNM) CEO Siegall buys $100k in shares
Immunome: Guggenheim bestätigt Kaufempfehlung nach 400-Millionen-Dollar-Finanzierung
Guggenheim reiterates Buy rating on Immunome stock following $400M financing
Insiderkauf bei Immunome: CEO Siegall erwirbt Aktien für 149.000 $/n
Immunome: Technikvorstand Philip Tsai kauft Aktien für 204.899 US-Dollar
Tsai Philip buys $204,899 in Immunome stock
Immunome: Maintaining "Strong Buy" On Successful RINGSIDE Trial With Varegacestat (IMNM)
Avago and Oracle among market cap stock movers on Wednesday